Hinge Health, Inc. Class A Common Stock (HNGE)
R&D Expenses
$129.07M
TTM · Period ending: · USD
HNGE R&D Expenses
Latest reported$129.07Mperiod ending
Latest reported$129.07Mperiod ending
HNGE R&D Expenses ($110.06M → $129.07M)
Annual R&D Expenses
High-resolution chart · PNG
HNGE r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 368,137,000 | |
| 100,839,000 | |
| 110,058,000 |